Free Energy Team Lead

Aqemia; London; Hybrid; GBP 45,000 - 80,000; Full time

Job summary

Join a forward-thinking pharmatech company that is revolutionizing drug discovery through innovative AI and quantum-inspired algorithms. At this dynamic firm, you'll be part of an interdisciplinary team focused on critical therapeutic areas such as oncology and CNS. With a strong financial backing and a mission to make a significant impact on the healthcare landscape, this role offers the chance to contribute to groundbreaking projects while enjoying a flexible work environment. If you're passionate about shaping the future of pharmaceuticals, this opportunity is perfect for you.

Benefits

Relocation support

French lessons

Flexible workdays

International environment

Qualifications

• Experience in drug discovery and development processes.
• Strong understanding of AI applications in pharmaceuticals.

Responsibilities

• Design innovative drug candidates using generative AI.
• Collaborate with interdisciplinary teams to advance drug discovery.

Skills

Quantum-inspired physics algorithms

Generative AI

Drug discovery

Immuno-oncology

Collaboration with pharmaceutical companies

Education

Degree in Life Sciences or related field

Advanced degree (Master's or PhD)

Job description

About AQEMIA

AQEMIA is a next-generation pharmatech company developing one of the world's fastest-growing drug discovery pipelines.

Our mission is to design fast, innovative drug candidates for critical diseases such as immuno-oncology.

We leverage quantum-inspired physics algorithms to power generative AI in designing novel drug candidates—without relying on experimental data.

We have achieved several drug discovery successes within our internal pipeline and through collaborations with pharmaceutical companies. Our most advanced programs are currently in in vivo optimization.

Why Join Us?

At AQEMIA, we are on a mission: joining us means making a significant impact on how drugs are discovered and helping shape the growth of our company and team.

Expanding Drug Discovery Pipeline: Focused on critical therapeutic areas like Oncology, CNS, and Immuno-inflammation, with in vivo proof of concept and patent-stage programs. We collaborate with top pharma companies, including a $140M deal with Sanofi.

Interdisciplinary Team: Comprising talented professionals from tech and life sciences.

DeepTech Recognition: Part of French Tech 120 and France 2030 initiatives.

Prime Location: Based in central Paris and London (King's Cross), with the possibility of two remote workdays per week.

International Environment: The working language is English. We offer relocation support and French lessons if needed.

Strong Financial Backing: Raised $100M from leading European and international investors.